However, FOXO4-DRI breaks this link
Limitations of this review This review systematically summarizes the pharmacokinetic basis, multi-organ toxicity mechanisms, chemoresistance link, clinical challenges, and intervention strategies of in vivo platinum accumulation from platinum-based chemotherapeutics
These technologies enhance operational efficiency, improve patient retention, and support the expansion of IV therapy services across multiple locations
They are granted a narrow legal exemption from the standard New Drug Application (NDA) process only if they strictly adhere to the requirements of the following statutory pathways: Section 503A (Traditional Compounding): Regulates state-licensed pharmacies compounding for identified individual patients based on a valid, patient-specific prescription
10.1021/acsomega.1c04239 238 ZhangJ.GaoJ.-X.SalojinK.ShaoQ.GrattanM.MeagherC.et al (2000)